Autoimmune diseases affect nearly 4 per cent of the world’s population and there’s a rising prevalence of su...
China's Porton Advanced Solutions has announced a strategic cooperation with Suzhou Royaltech Med Co. to jointly promote...
Eisai Inc., the US pharmaceutical subsidiary of Japanese firm Eisai Co, has announced the grand opening of its new headq...
AstraZeneca and Merck, known as MSD outside of the United States and Canada, have announced that LYNPARZA has been appro...
The Therapeutic Goods Administration (TGA) led Australia's participation in INTERPOL's Operation Pangea, which tackles t...
Indian firm Lupin has entered into an exclusive licensing agreement with I’rom Group, a leading pharmaceutica...
Japanese firm Eisai has entered into a Memorandum of Understanding with US-based C2N Diagnostics that will seek to build...
South Korea-based startup Standigm Inc. has announced the appointment of Chief Business Officer Carl Foster. Based ...
Jemincare, a leading pharmaceutical company from China, has entered into an exclusive worldwide license agreement w...
Japanese firms Chugai Pharmaceutical and Towa Pharmaceutical have announced that Chugai has obtained regulatory approval...
China's Everest Medicines has entered into an agreement with Immunomedics, Inc., a wholly-owned subsidiary of Gilea...
Hong Kong-based startup Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discover...
China's Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmace...
China's Asieris Pharmaceuticals, a global biopharma company specializing in discovering and developing innovative drugs ...
Australian biotechnology company Starpharma has signed a new DEP Research Agreement with MSD, the trade name of Mer...
Verizon Business has been selected to manage Astellas Pharma's (Astellas) global network infrastructure. The network tra...
Astellas Pharma has announced the appintment of a new Chief Medical Officer (CMO)- Dr Tadaaki Taniguchi, as of...
Australia-based Telix Pharmaceuticals has been jointly awarded a $4.8 million Australian Research Council (ARC) grant to...
German firm Grünenthal and Japan-based Shionogi have entered into a licensing agreement for Grünenthal's inves...
As pharma shifts from generic drugs to personalised medicines, it has become apparent that conventional systems lack the...
Singapore's Prestige Biopharma and India's Intas Pharmaceuticals have announced that the two companies have entered...
China's Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and...
Baxter International, a global medtech leader, has announced the appointment of Steven (Steve) Flynn to Senior Vice Pres...
Brii Biosciences has announced that TSB Therapeutics (Beijing), a joint venture majority-owned by the company, is ...
Simcere Pharmaceuticals has announced that the China National Medical Products Administration (NMPA) has conditionally a...
